BRPI0516963A - ácido nucleico, plasmìdeo, composição veterinária, vacina, métodos de proteção de aves domésticas de colonização por campylobacter e de proteção de um humano de infecção por campylobacter, uso de um ácido nucleico, um plasmìdeo, uma composição, ou uma vacina, e, alimento - Google Patents

ácido nucleico, plasmìdeo, composição veterinária, vacina, métodos de proteção de aves domésticas de colonização por campylobacter e de proteção de um humano de infecção por campylobacter, uso de um ácido nucleico, um plasmìdeo, uma composição, ou uma vacina, e, alimento

Info

Publication number
BRPI0516963A
BRPI0516963A BRPI0516963-1A BRPI0516963A BRPI0516963A BR PI0516963 A BRPI0516963 A BR PI0516963A BR PI0516963 A BRPI0516963 A BR PI0516963A BR PI0516963 A BRPI0516963 A BR PI0516963A
Authority
BR
Brazil
Prior art keywords
campylobacter
vaccine
nucleic acid
plasmid
protecting
Prior art date
Application number
BRPI0516963-1A
Other languages
English (en)
Inventor
Diane Newell
Shaun Cawthraw
Original Assignee
Sec Dep For Environment Food A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sec Dep For Environment Food A filed Critical Sec Dep For Environment Food A
Publication of BRPI0516963A publication Critical patent/BRPI0516963A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)

Abstract

CIDO NUCLEICO, PLASMìDEO, COMPOSIçãO VETERINáRIA, VACINA, MéTODOS DE PROTEçãO DE AVES DOMéSTICAS DE COLONIZAçãO POR CAMPYLOBACTER E DE PROTEçãO DE UM HUMANO DE INFECçãO POR CAMPYLOBACTER, USO DE UM áCIDO NUCLEICO, UM PLASMìDEO, UMA COMPOSIçãO, OU UMA VACINA, E, ALIMENTO. ácidos nucleicos codificando proteínas de Campylobacter, particularmente proteínas antigênicas como flagelina, ou codificando um seu variante, ou um fragmento de qualquer uma destas, são capazes de proteger aves domésticas como galinhas, contra a colonização por Campylobacter, e assim podem ser usados em terapia ou profilaxia veterinária. Isto tem um impacto sobre a saúde humana.
BRPI0516963-1A 2004-10-26 2005-10-25 ácido nucleico, plasmìdeo, composição veterinária, vacina, métodos de proteção de aves domésticas de colonização por campylobacter e de proteção de um humano de infecção por campylobacter, uso de um ácido nucleico, um plasmìdeo, uma composição, ou uma vacina, e, alimento BRPI0516963A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0423681.6A GB0423681D0 (en) 2004-10-26 2004-10-26 Vaccine and nucleic acids
PCT/GB2005/004102 WO2006046017A2 (en) 2004-10-26 2005-10-25 Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter

Publications (1)

Publication Number Publication Date
BRPI0516963A true BRPI0516963A (pt) 2008-09-30

Family

ID=33485172

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516963-1A BRPI0516963A (pt) 2004-10-26 2005-10-25 ácido nucleico, plasmìdeo, composição veterinária, vacina, métodos de proteção de aves domésticas de colonização por campylobacter e de proteção de um humano de infecção por campylobacter, uso de um ácido nucleico, um plasmìdeo, uma composição, ou uma vacina, e, alimento

Country Status (9)

Country Link
US (1) US20070249553A1 (pt)
EP (1) EP1807110A2 (pt)
JP (1) JP2008517595A (pt)
CN (1) CN101087620A (pt)
AU (1) AU2005298488A1 (pt)
BR (1) BRPI0516963A (pt)
CA (1) CA2585354A1 (pt)
GB (1) GB0423681D0 (pt)
WO (1) WO2006046017A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9047864B2 (en) 2009-07-16 2015-06-02 Washington State University Antigen compositions and methods of inhibiting Campylobacter jejuni bacterial infection and uses of the antigen compositions
CN102811734B (zh) 2010-01-21 2016-02-10 阿肯色大学评议会 增强免疫应答的疫苗载体和方法
CA2800830C (en) * 2010-06-09 2020-09-08 The Board Of Trustees Of The University Of Arkansas Vaccine and methods to reduce campylobacter infection
CN103087160B (zh) * 2011-10-31 2014-03-12 中国科学院微生物研究所 一种鞭毛运动蛋白及其编码基因和它们的应用
DK3068384T3 (da) * 2012-02-16 2019-08-12 Akeso Biomedical Inc Jernkomplekser til reducering af gastrointestinalkanal-kolonisering med campylobacter
US10376571B2 (en) 2013-03-15 2019-08-13 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
CA2957790A1 (en) 2014-08-13 2016-02-18 Akeso Biomedical, Inc. Antimicrobial compounds and compositions, and uses thereof
US10653658B2 (en) 2015-08-11 2020-05-19 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
CA2995408C (en) 2015-08-11 2021-01-05 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
KR20190015712A (ko) 2016-05-03 2019-02-14 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법
US12297258B2 (en) * 2018-07-17 2025-05-13 Humabs Biomed Sa Antibodies against Campylobacter species
CN121064339A (zh) * 2025-08-22 2025-12-05 南京澄实生物医药科技有限公司 一种预防铜绿假单胞菌感染的免疫原性组合物及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888810A (en) * 1993-11-12 1999-03-30 The United States Of America As Represented By The Secretary Of Agriculture Campylobacteri jejuni flagellin-escherichia coli LT-B fusion protein
US5827654A (en) * 1995-05-08 1998-10-27 University Of Toronto Basal body rod protein genes of campylobacter
US6087105A (en) * 1997-04-08 2000-07-11 Chan; Voon Loong Gene encoding invasion protein of campylobacter species
US6211159B1 (en) * 1997-04-11 2001-04-03 University Of Toronto Flagellin gene, FlaC of campylobacter
US20010038844A1 (en) * 1998-05-04 2001-11-08 Irving Nachamkin Methods and vaccines for protection against campylobacter infections
EP0974660A1 (en) * 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle disease virus infectious clones, vaccines and diagnostic assays
AU1820800A (en) * 1998-11-12 2000-05-29 United States Of America As Represented By The Secretary Of The Navy, The A recombinant polypeptide for use in the manufacture of vaccines against campylobacter induced diarrhea and to reduce colonization
KR100773109B1 (ko) * 1999-05-06 2007-11-02 웨이크 포리스트 유니버시티 면역 반응을 유발하는 항원을 동정하기 위한 조성물과 방법
WO2000077227A1 (en) * 1999-06-16 2000-12-21 Bristol-Myers Squibb Company Fibrin sealant as a transfection/transformation vehicle for gene therapy
EP1246848A1 (en) * 1999-12-27 2002-10-09 University Of Manitoba GENETIC VACCINES FOR THE PRODUCTION OF CHICKEN EGG-YOLK ANTIBODIES AGAINST ENTEROTOXIGENIC i ESCHERICHIA COLI /i AND OTHER PATHOGENS
US6821955B2 (en) * 2000-04-07 2004-11-23 Baylor College Of Medicine Macroaggregated protein conjugates as oral genetic immunization delivery agents
US7192725B2 (en) * 2000-05-19 2007-03-20 University Of Toronto Flagellin gene, flaC of Campylobacter
JP2004510723A (ja) * 2000-10-06 2004-04-08 ヤゴテック　アーゲー 低下した分子量のアミロペクチンをベースとする精製された澱粉を含む制御放出投与のための生物分解性微粒子
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
EP1250933A1 (en) * 2001-04-17 2002-10-23 Istituto Superiore di Sanità Vaccines including as an adjuvant high dose type I IFN
ATE357219T1 (de) * 2002-01-25 2007-04-15 Glaxo Group Ltd Darreichungsformen für dns
US7569553B2 (en) * 2002-07-03 2009-08-04 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7807803B2 (en) * 2002-07-03 2010-10-05 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US20050106159A1 (en) * 2003-08-12 2005-05-19 Thompson Stuart A. Campylobacter jejuni outer membrane protein immunogenic composition
WO2006039701A1 (en) * 2004-10-01 2006-04-13 University Of South Florida Flagellin-based adjuvants and vaccines

Also Published As

Publication number Publication date
JP2008517595A (ja) 2008-05-29
GB0423681D0 (en) 2004-11-24
WO2006046017A3 (en) 2006-09-14
EP1807110A2 (en) 2007-07-18
CN101087620A (zh) 2007-12-12
AU2005298488A1 (en) 2006-05-04
WO2006046017A8 (en) 2006-12-14
US20070249553A1 (en) 2007-10-25
CA2585354A1 (en) 2006-05-04
WO2006046017A2 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
BR112022014808A2 (pt) Composições e métodos para vacinas para prevenir e tratar infecção pelo coronavírus-sars-cov-2
WO2008073891A3 (en) Salmonella vaccine in poultry
BR112017024331A2 (pt) composto, composição farmacêutica, método de tratamento de um humano, métodos para inibir a atividade de uma proteína ido1, o crescimento ou a proliferação de células cancerosas, e a imunossupressão em um paciente, e de tratamento de uma doença, e, uso de um composto
WO2015149944A3 (en) Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
WO2007126816A3 (en) Methods and compositions for vaccination of poultry
BRPI0821286A8 (pt) Métodos e composições para imunizar porcos contra circovirus suino
AR089797A1 (es) Vacunas contra clostridum difficile que comprenden toxinas recombinantes
CU23734A1 (es) Polipéptidos inmunomoduladores derivados de la il-2 con actividad antagonista de esta citocina útiles en la terapia del cáncer y enfermedades infecciosas crónicas
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
BRPI0815578B8 (pt) Peptídeo de cdca1, seu uso e composição imunogênica compreendendo o mesmo para induzir imunidade, tratar e/ou prevenir o câncer, bem como método in vitro para induzir uma célula apresentadora de antígeno e uma célula t citotóxica (killer)
BRPI0918806A2 (pt) composição compreendendo quitosana para administração ocular de vaninas em aves
BR112022016893A2 (pt) Vacina contra a infecção do vírus da peste suína africana
BR112014001409A2 (pt) métodos e composições para vacinação contra staphylococcus aureus
PH12013501373B1 (en) Bovine viral diarrhea virus type 1b vaccine compositions and methods
BR112015022582A2 (pt) molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
CO6460752A2 (es) Respuesta inmunitaria reforzada en especies aviares
Lazarte et al. Enhancement of glycoprotein-based DNA vaccine for viral hemorrhagic septicemia virus (VHSV) via addition of the molecular adjuvant, DDX41
BR112016002354A2 (pt) composição imunogênica, métodos para proteger um bebê contra infecção ou doença e para evocar uma resposta imune, regime de vacinação, e, kit
AR094725A1 (es) Parvovirus 5a porcino, métodos de uso y vacuna
WO2006046017A8 (en) Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter
Rahman et al. Oral co-administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α and interleukin-18 enhances the alleviation of clinical signs caused by respiratory infection with avian influenza virus H9N2
AR020084A1 (es) Pestivirus atenuados
WO2010033337A8 (en) Rabies virus-based recombinant immunocontraceptive compositions and methods of use
ATE442857T1 (de) Vakzine zusammensetzung zur impfung von hunden gegen infektiöse atemwegserkrankung bei hunden (cird)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.